WallStreetZenWallStreetZen

NYSE: ADCT
Adc Therapeutics Sa Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Adc Therapeutics Sa earnings were -$149.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ADCT earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$38.6M, up 25.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADCT reported annual earnings of -$157.8M, with -34.2% growth. The next ADCT earnings date is Aug 12, 2025.

ADCT earnings history

Current Revenue
$75.8M
Current Earnings
-$149.8M
Current Profit Margin
-197.6%

ADCT Return on Equity

Current Company
N/A
Current Industry
-60.2%
Current Market
31.3%

ADCT undefined

Current Company
-45.6%
Current Industry
-2.5%
ADCT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ADCT announces earnings.

ADCT undefined

Current Company
-46.44%
Current Industry
5.8%
ADCT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADCT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ADCT-$96.50M-$149.84MN/A-$1.43
SCPH-$83.77M-$90.78MN/A-$1.87
NKTR-$102.43M-$133.04MN/A-$9.45
REPL-$235.43M-$247.30MN/A-$3.07
BNTC-$24.79M-$27.11MN/A$0.00
View Top Biotech Stocks

ADCT earnings dates

Next earnings date
Aug 12, 2025

Adc Therapeutics Sa Earnings Reports & History FAQ

What were Adc Therapeutics Sa's earnings last quarter?

On ADCT's earnings call on Invalid Date, Adc Therapeutics Sa (NYSE: ADCT) reported Q1 2025 earnings per share (EPS) of -$0.36, up 35.71% year over year. Total ADCT earnings for the quarter were -$38.60 million. In the same quarter last year, Adc Therapeutics Sa's earnings per share (EPS) was -$0.56.

If you're new to stock investing, here's how to buy Adc Therapeutics Sa stock.

When does Adc Therapeutics Sa report earnings?

The next ADCT earnings date is Invalid Date. Add ADCT to your watchlist to be reminded of Adc Therapeutics Sa's next earnings date.

Is Adc Therapeutics Sa profitable or losing money?

As of the last Adc Therapeutics Sa earnings report, Adc Therapeutics Sa is currently losing money. Adc Therapeutics Sa's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$149.84 million, a 34.07% decrease year over year.

What was ADCT's earnings growth in the past year?

As of Adc Therapeutics Sa's earnings date in Invalid Date, Adc Therapeutics Sa's earnings has grown year over year. ADCT earnings in the past year totalled -$149.84 million.

What are Adc Therapeutics Sa's earnings expectations?

The current EPS estimate for Adc Therapeutics Sa's earnings report in Invalid Date is -$0.39.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.